(Q37815438)

23 August 2017

1 reference

title

Novel natriuretic peptides: new compounds and new approaches (English)

1 reference

23 August 2017

Mark W Vogel

1

1 reference

23 August 2017

Horng H Chen

series ordinal

2

1 reference

23 August 2017

language of work or name

1 reference

1 March 2011

1 reference

Current heart failure reports

23 August 2017

published in

1 reference

23 August 2017

volume

8

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

22-27

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-010-0038-0

23 August 2017

exact match

0 references

cites work

Natriuretic effect of atrial extract on isolated perfused rat kidney.

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Natriuretic peptides in the pathophysiology of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Renal actions of synthetic dendroaspis natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Novel bifunctional natriuretic peptides as potential therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Subcutaneous administration of brain natriuretic peptide in experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Intact acute cardiorenal and humoral responsiveness following chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-010-0038-0

Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro

21 January 2018

1 reference

12 December 2020

Effects of synthetic atrial natriuretic factor on renal function and renin release

1 reference

12 December 2020

Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation

1 reference

12 December 2020

A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps)

1 reference

12 December 2020

Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the

1 reference

12 December 2020

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.

1 reference

12 December 2020

Therapeutic potential for existing and novel forms of natriuretic peptides

1 reference

12 December 2020

Renal effects of ularitide in patients with decompensated heart failure

1 reference

12 December 2020

Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart.

1 reference

12 December 2020

Atrial natriuretic peptide elevation in congestive heart failure in the human

1 reference

12 December 2020

Vascular actions of brain natriuretic peptide: modulation by atherosclerosis and neutral endopeptidase inhibition

1 reference

12 December 2020

10.1007/S11897-010-0038-0

Identifiers

DOI

1 reference

23 August 2017

1 reference